DMK PHARMACEUTICALS CORP (DMK) Stock Analyst Ratings
USA - NASDAQ:DMK - US00547W3079 - Common Stock
0.232 USD
+0 (+0.91%)
0.1665 USD
-0.07 (-28.23%)
ChartMill assigns a Buy % Consensus number of 80% to DMK. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.53. This target is 559.48% above the current price.
DMK was analyzed by 5 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about DMK.
In the previous month the buy percentage consensus was at a similar level.
Only 5 analysts analyzed DMK. So this is just the average opinion of a couple of analysts.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-12-07 | Maxim Group | Initiate | Buy |
DMK PHARMACEUTICALS CORP / DMK FAQ
Can you provide the average price target for DMK PHARMACEUTICALS CORP stock?
5 analysts have analysed DMK and the average price target is 1.53 USD. This implies a price increase of 559.48% is expected in the next year compared to the current price of 0.232.
How do analysts rate DMK PHARMACEUTICALS CORP (DMK)?
The consensus rating for DMK PHARMACEUTICALS CORP (DMK) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.